Hard Capsule Lead Times Hit 14 Weeks as Manufacturers Hike MOQs to 25000 Units
EU contract manufacturers are raising minimum order quantities and extending lead times to manage Q4 capacity. Procurement must lock in 2027 forecasts by August to avoid stockouts.
The EU supplement manufacturing landscape is tightening as we enter the third quarter. Major contract manufacturers in Germany, Poland, and the Netherlands have officially moved their standard lead times for hard capsules from 10 weeks to 14 weeks since June. Brands operating on lean inventory models must adjust their buffer stocks immediately.
MOQ Shifts and Pricing Pressure
Tier 1 facilities are no longer entertaining small runs for complex botanical blends. The shift toward higher volume is driven by labor costs and machine downtime during cleaning validation for high staining ingredients like Turmeric and Beetroot.
- Standard Hard Capsule MOQs: Increased from 10000 to 25000 units per SKU.
- Softgel Lead Times: Current average is 18 weeks due to gelatin supply constraints and encapsulated oil demand.
- Small Batch Surcharge: Manufacturers are charging a flat 1200 EUR fee for runs under 15000 units to cover setup costs.
Recommendations for Q4 and 2027 Planning
If you are launching a new formulation in the final quarter of 2026, switch to white label options where possible. Custom formulations submitted today will not hit warehouse shelves until late November at the earliest. For brands using Magnesium Malate or Citrate, consolidate your orders now; high volume powders are seeing the most aggressive MOQ hikes.
We expect lead times to peak at 16 weeks by September. Procurement managers should issue purchase orders for Q1 2027 demand before the end of August to lock in current price per unit rates and avoid the expected 4 percent labor cost adjustment coming in January.
Tell Jake what you need. Real EU supplier offers within a day.
